Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:20 PM
Ignite Modification Date:
2025-12-24 @ 2:20 PM
NCT ID:
NCT00522795
Eligibility Criteria:
Inclusion Criteria:
* Patients are required to have pathologically confirmed adenocarcinoma or squamous cell carcinoma of the esophagus or gastroesophageal junction
* Patients may have celiac adenopathy
* There must be no evidence of distant organ metastases
* No prior chemotherapy or radiation for esophageal cancer
* Patients must be \> 18 years of age, and non pregnant
* Patients must have an ANC \> 1,500/ul, platelets \> 100,000/ul, creatinine \< 2.0 and bilirubin \< 1.5 x ULN-ECOG performance status 0-1.
* Female patients, must either be not of child bearing potential or have a negative pregnancy test within 14 days of starting study treatment. Patients are considered not of child bearing potential if they are surgically sterile (they have undergone a hysterectomy, bilateral tubal ligation, or bilateral oophorectomy) or they are postmenopausal. Pregnant or lactating females are not eligible
* No contraindications to esophagectomy
* Signed informed consent
Exclusion Criteria:
* Active or uncontrolled infection
* Patients must not have other coexistent medical condition that would preclude protocol therapy.
* Any concurrent chemotherapy not indicated in the study protocol or any other investigational agent(s).
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
19 Years
Study:
NCT00522795
Study Brief:
Protocol Section:
NCT00522795